167 related articles for article (PubMed ID: 33118832)
1. Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma.
Xie GF; Xu YX; Xu F; Sun LY; Ye ZL; Ma JJ; Wang HY; Shao JY
Neoplasma; 2021 Jan; 68(1):62-70. PubMed ID: 33118832
[TBL] [Abstract][Full Text] [Related]
2. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
[TBL] [Abstract][Full Text] [Related]
6. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
[TBL] [Abstract][Full Text] [Related]
7. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
[TBL] [Abstract][Full Text] [Related]
9. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
10. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Qian Y; Wang JW; Fang Y; Yuan XD; Fan YC; Gao S; Wang K
Med Sci Monit; 2020 Dec; 26():e927444. PubMed ID: 33320844
[TBL] [Abstract][Full Text] [Related]
12. Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma.
Liu XY; Fan YC; Gao S; Zhao J; Chen LY; Li F; Wang K
Neoplasma; 2017; 64(5):745-753. PubMed ID: 28592127
[TBL] [Abstract][Full Text] [Related]
13. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
[TBL] [Abstract][Full Text] [Related]
15. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma.
Miao LL; Wang JW; Liu HH; Gao S; Fan YC; Wang K
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):35-42. PubMed ID: 36878837
[TBL] [Abstract][Full Text] [Related]
18.
Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]